Viewing Study NCT05699135


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-25 @ 8:12 PM
Study NCT ID: NCT05699135
Status: TERMINATED
Last Update Posted: 2024-04-24
First Post: 2022-12-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module